Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease. Wright JR, Deen QFE, Stevenson A, Telford-Cooke L, et al. J Alzheimers Dis 2022 Sep 1. pii: JAD220642. doi: 10.3233/JAD-220642.

Read + Share

Amedeo Smart

Independent Medical Education

Wright JR, Deen QFE, Stevenson A, Telford-Cooke L, et al. Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease. J Alzheimers Dis 2022 Sep 1. pii: JAD220642. doi: 10.3233/JAD-220642.
PMID: 36057826